1 mg tirzepatide Hush Medical Spa Tirzepatide Flex-Dose 1 mL Injectable

What if you lost weight and didnt care about anything?

The development of dual GIPRGLP1R coagonists that bind to either one or the other receptor (sequence-mixed dual agonists) has emerged as an innovative therapeutic strategy for obesity and type 2 diabetes

Roches oral GLP-1 receptor agonist CT-996obtained in the $2.7 billion acquisition of Carmot Therapeuticsreduced body weight by more than 6% at four weeks versus placebo in a Phase I trial.

GLP-1 agonists vs retatrutide for fat loss: head-to-head on efficacy, safety, and practical use

Read this!

Recent Findings Results from CV outcomes trials have demonstrated the efficacy of GLP-1 RA and dual GLP-1/GIP receptor agonists to promote weight loss and improve CV outcomes across diverse populations, including reduced risk of major adverse CV events and mortality, progression of chronic kidney disease, as well as improvements in quality of life and functional status